Skip to main content
KMTS logo
KMTS
(NASDAQ)
Kestra Medical Technologies, Ltd.
$19.84-- (--)
Loading... - Market loading

Kestra Medical Technologies (KMTS) Cash Flow Statement

Operating, investing, and financing activities with annual and quarterly data.

Kestra Medical Technologies Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Kestra Medical Technologies, Ltd. (KMTS) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2021FY 2019
Period EndingApr 2025Apr 2024Apr 2023Apr 2021Apr 2020
Operating Activities
Net Income-113.81-84.24-84.24-34.10-29.47
Depreciation & Amortization7.974.864.860.420.48
Deferred Income Tax0.060.01-0.050.000.00
Stock Based Compensation24.271.491.211.860.00
Change in Working Capital-6.201.301.30-0.02-2.01
Change in Accounts Receivable-8.78-2.500.000.000.00
Change in Inventory-3.44-0.73-0.730.000.00
Change in Accounts Payable2.842.142.14-0.13-0.79
Change in Other Working Capital2.67-0.11-0.111.90-1.22
Other Operating Activities2.676.237.281.900.71
Net Cash from Operating Activities-77.61-72.24-69.64-29.90-30.29
Investing Activities
Capital Expenditures-23.59-12.23-15.46-0.34-0.23
Other Investing Activities0.280.290.000.000.00
Net Cash from Investing Activities-23.31-12.23-15.46-0.33-0.23
Financing Activities
Debt Repayment0.005.88-5.3320.000.00
Common Stock Issued215.790.000.0030.330.00
Dividends Paid-1.65-0.80-0.67-0.19-0.18
Other Financing Activities12.73-3.15102.1129.0030.42
Net Cash from Financing Activities330.2677.7396.1148.8230.24
Summary
Net Change in Cash229.35-6.7411.0018.59-0.29
Cash at Beginning of Period8.5815.324.326.276.55
Cash at End of Period237.938.5815.3224.856.27
Free Cash Flow-101.20-84.46-85.10-30.23-30.53
Supplemental Disclosures
Interest Paid4.853.630.000.000.00
Income Taxes Paid0.080.010.000.210.00

Frequently Asked Questions About Kestra Medical Technologies Cash Flow

What is a cash flow statement?

A cash flow statement tracks the actual cash moving in and out of a company during a period. It's divided into three sections: operating activities (core business), investing activities (assets and investments), and financing activities (debt and equity). Unlike the income statement, it shows real cash rather than accounting profits.

What is operating cash flow?

Operating cash flow is the cash generated from a company's core business operations. It adjusts net income for non-cash items like depreciation and changes in working capital. Strong operating cash flow indicates the business can fund operations without external financing.

What is free cash flow (FCF)?

Free cash flow is operating cash flow minus capital expenditures. It represents the cash available for dividends, share buybacks, debt repayment, or reinvestment. FCF is considered one of the most important metrics for evaluating a company's financial health.

What are capital expenditures?

Capital expenditures (CapEx) are funds spent on acquiring or maintaining physical assets like property, equipment, and technology. CapEx appears in the investing activities section and is subtracted from operating cash flow to calculate free cash flow.

How is KMTS's cash generation trending?

Review Kestra Medical Technologies's operating cash flow and free cash flow figures in the quarterly and annual data above. Consistent growth in operating cash flow relative to net income indicates high-quality earnings.

These financial metrics are calculated using cash flow data. Learn how each metric works and screen stocks by them.